Phaseline

Companies › Merz Therapeutics

Merz Therapeutics: clinical trials, targets and expected readouts

1 active drug program in 10 registered trials: 4 Phase 3, 4 Phase 2, 2 Phase 4; Neurology, Genitourinary, Immunology, Other; next expected readout Mar 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Incobotulinumtoxina
Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
SNAP25Phase 3Chronic Migraine; Episodic Migraine; Fissure in Ano; Stroke …Mar 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT03855046IncobotulinumtoxinaPhase 4Fissure in AnoGenitourinarySep 2022
NCT03571334IncobotulinumtoxinaPhase 2Peripheral Neuropathy Due to ChemotherapyNeurologyDec 2023
NCT05456087IncobotulinumtoxinaPhase 2Androgenetic AlopeciaImmunologyDec 2024
NCT07486830IncobotulinumtoxinaPhase 2Provoked VestibulodyniaGenitourinaryDec 2026
NCT05327972IncobotulinumtoxinaPhase 2Degenerative Rotator Cuff DiseaseOtherFeb 2027
NCT05598723IncobotulinumtoxinaPhase 3Chronic MigraineNeurologyFeb 2027
NCT07018713IncobotulinumtoxinaPhase 3Chronic MigraineNeurologyMar 2027
NCT07018700IncobotulinumtoxinaPhase 3Episodic MigraineNeurologyMar 2027
NCT03977493IncobotulinumtoxinaPhase 3Focal Hand DystoniaNeurologyDec 2027
NCT04908423IncobotulinumtoxinaPhase 4StrokeNeurologyApr 2028

Targets

SNAP25 (1)

Companies with the same targets

AbbVie Biojiva Ipsen Huons Biopharma Merz Aesthetics Merz Pharmaceuticals Merz North America

Companies built like this

Merz Pharmaceuticals Merz Aesthetics Merz North America Hansa Biopharma Chongqing Claruvis Pharmaceutical

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.